Amiel J L, Droz J P, Tursz T, Ayed F B, Gastiaburu J, Rouesse J
J Gynecol Obstet Biol Reprod (Paris). 1979 Jan-Feb;8(1):65-6.
Cis-diamminedichloroplatinum is remarkably useful in stage III and IV cancers of the ovary. It should therefore be added to the armamentarium of chemotherapeutic substances used up till now. This effectiveness adds extra indication to the use of chemotherapy as a first treatment for stage III cancers of the ovary after the lesions have been reduced as far as possible by surgery.
顺二氯二氨铂在卵巢癌的 III 期和 IV 期治疗中非常有用。因此，它应被添加到目前为止所使用的化疗药物库中。这种有效性为化疗作为卵巢癌 III 期的首选治疗方法增加了额外的适应症，前提是在通过手术尽可能缩小病变后进行化疗。
